CN109157536A - A kind of control method of duck plague disease - Google Patents

A kind of control method of duck plague disease Download PDF

Info

Publication number
CN109157536A
CN109157536A CN201810836909.9A CN201810836909A CN109157536A CN 109157536 A CN109157536 A CN 109157536A CN 201810836909 A CN201810836909 A CN 201810836909A CN 109157536 A CN109157536 A CN 109157536A
Authority
CN
China
Prior art keywords
injection
duck
duck plague
plague disease
control method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810836909.9A
Other languages
Chinese (zh)
Inventor
李俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou Wanli Rural Agricultural Development Co Ltd
Original Assignee
Guizhou Wanli Rural Agricultural Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou Wanli Rural Agricultural Development Co Ltd filed Critical Guizhou Wanli Rural Agricultural Development Co Ltd
Priority to CN201810836909.9A priority Critical patent/CN109157536A/en
Publication of CN109157536A publication Critical patent/CN109157536A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention provides a kind of control methods of duck plague disease, and this method carries out intramuscular injection using joint injection agent made of acyclovir, rimantadine hydrochloride, dipyrimidinol, to sick duck, rapid-action, and for preventing and treating duck plague disease, effect highly significant, prevention and treatment is simply.

Description

A kind of control method of duck plague disease
Technical field
The invention belongs to cultural technique fields, and in particular to a kind of control method of duck plague disease
Background technique
Duck, duck are the general designations of Anseriformes Anatidae duck subfamily aquatic bird, mainly with the toy (fish, shrimp, loach etc.) in water, Plant (water plant, barnyard grass, rice etc.) is food.It is divided into laying duck and duckling, duck's egg nutritive value is high, the fatty acid fusing point in duck It is low, it is easy to digest.Contained B family vitamin and vitamin E are more compared with other meats, are highly resistant to athlete's foot, neuritis and a variety of Inflammation, moreover it is possible to anti-aging.Contain niacin more abundant in duck, it be constitute two kinds of important coenzyme in human body at point it One, there is protective effect to heart disease patients such as myocardial infarctions.
Duck plague (Duck plape0) also known as duck viral enteritis (Duck virusenteritis, DVE), be duck, goose and A kind of acute, hot, Septic blood infectious disease of other Anseriformes birds.The disease is characterized in prevalence extensively, propagates morbidity rapidly Rate and the death rate are all high.This disease is found for the first time in Holland early in nineteen twenty-three BaudetShi, until BosShi in 1940 is put forward for the first time duck The title of pest, and confirm it is a kind of new virus disease different from checken pest.Currently, there is no specific drug, often aim at prevention, except carrying out Outside biological safety measure, the occurrence of this disease can effectively be prevented by carrying out immunity inoculation using duck plague attenuated live vaccines.Duck mass-sending When sick, to healthy duck group or suspected infection duck, 3-4 times of amount of duck plague vaccine should be taken promptly to be inoculated with immediately;To sick duck, every The duck plague hyper-immune serum duck poison of the great high-tech of intramuscular injection state is 0.5 milliliter or 0.5-1 milliliters of poly IC anti-, injects 1 time within every 3 days, 2-3 is used in conjunction It is secondary, carry out early treatment.The mixed drink of water can also be mixed with Moroxydine Hydrochloride soluble powder or Enrofloxacin soluble powder, it is l-2 times daily, It is used in conjunction 3-5 days, but is not applied to laying ducks, meat duck is pre-sales should to be discontinued 8 days.The same slaughter of sick duck and buried processing.It is right simultaneously The all goods that sick duck may contact carry out thorough disinfection.But above-mentioned therapeutic effect is to be improved, and medicament residue is caused to pollute, It is unfavorable for the production of duck product.
Summary of the invention
Of the existing technology to overcome the problems, such as, the present invention provides a kind of control method of duck plague disease, this method is used Acyclovir, rimantadine hydrochloride, joint injection agent made of dipyrimidinol carry out intramuscular injection to sick duck, rapid-action, For preventing and treating duck plague disease, effect highly significant, prevention and treatment is simply.
Specifically, the present invention provides a kind of control methods of duck plague disease, comprising the following steps:
(1) preparation of duck plague disease injection: take acyclovir 1-4g, rimantadine hydrochloride 1-4g, dipyrimidinol 2-6g, It is put into injection water 600-800ml, holding temperature is 60-70 DEG C of stirring and dissolving, hyperfiltration, the hydroxide of 0.5mol/L It is 7.0-7.5 that sodium solution, which adjusts PH, and encapsulating sterilizes 30 minutes through 115 DEG C, pressure 0.2MPa, and every 5ml obtains injection;
(2) treatment of duck plague disease: illness duck is rejected into isolation treatment, gives injection injection 2-5ml of the present invention.
(3) duck plague disease is prevented: to sick duck is not suffering from, only being prevented using injection intramuscular injection 1-3ml/ of the invention.
Further, acyclovir 2-3g, rimantadine hydrochloride the preparation of the step (1) duck plague disease injection: are taken 2-3g, dipyrimidinol 3-5g, it is put into injection water 650-750ml, holding temperature is 60-70 DEG C of stirring and dissolving, ultra micro Filtering, it is 7.0-7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, and encapsulating sterilizes 30 minutes through 115 DEG C, pressure 0.2MPa, Every 5ml, obtains injection;
Still further, the preparation of (1) duck plague disease injection: taking acyclovir 2.5g, rimantadine hydrochloride 2.5g, dipyrimidinol 4g, be put into injection water 700ml, holding temperature be 65 DEG C of stirring and dissolvings, hyperfiltration, It is 7.0-7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, and encapsulating sterilizes 30 minutes, every through 115 DEG C, pressure 0.2MPa 5ml obtains injection;
The injection PH is preferably adjusted to 7.3;
The treatment of described step (2) the duck plague disease: illness duck is rejected into isolation treatment, gives injection injection of the present invention 3.5ml。
Step (3) the duck plague disease prevention: to sick duck is not suffering from, only using injection intramuscular injection 2ml/ of the invention Prevention.
The invention has the benefit that
The method of the present invention is using joint injection agent made of acyclovir, rimantadine hydrochloride, dipyrimidinol, to sick duck Intramuscular injection is carried out, rapid-action, for preventing and treating duck plague disease, effect highly significant, prevention and treatment is simply.Cure rate is up to 91%, in advance It is anti-efficient up to 99%.
Specific embodiment
Below with reference to preferred embodiment, the present invention is further explained.It should be understood that these embodiments are merely to illustrate The present invention rather than limit the scope of the invention.In addition, it should also be understood that, after reading the contents of the present invention, this field Technical staff can make various changes or modifications the present invention, and such equivalent forms equally fall within the application the appended claims Limited range.
The preparation of 1 duck plague disease injection of embodiment
It takes acyclovir 1g, rimantadine hydrochloride 1g, dipyrimidinol 2g, be put into injection water 600ml, heat preservation temperature Degree is 60 DEG C of stirring and dissolvings, and hyperfiltration, it is 7.0 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection;
The preparation of 2 duck plague disease injection of embodiment
It takes acyclovir 2g, rimantadine hydrochloride 2g, dipyrimidinol 3g, be put into injection water 650ml, heat preservation temperature Degree is 60 DEG C of stirring and dissolvings, and hyperfiltration, it is 7.0 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection;
The preparation of 3 duck plague disease injection of embodiment
It takes acyclovir 2.5g, rimantadine hydrochloride 2.5g, dipyrimidinol 4g, be put into injection water 700ml, protect Temperature is 65 DEG C of stirring and dissolvings, and hyperfiltration, it is 7.3 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, Pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection;
The preparation of 4 duck plague disease injection of embodiment
It takes acyclovir 3g, rimantadine hydrochloride 3g, dipyrimidinol 5g, be put into injection water 800ml, heat preservation temperature Degree is 70 DEG C of stirring and dissolvings, and hyperfiltration, it is 7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection;
The preparation of 5 duck plague disease injection of embodiment
It takes acyclovir 4g, rimantadine hydrochloride 4g, dipyrimidinol 5g, be put into injection water 800ml, heat preservation temperature Degree is 70 DEG C of stirring and dissolvings, and hyperfiltration, it is 7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection;
The preparation of 6 duck plague disease injection of embodiment
It takes acyclovir 2.5g, rimantadine hydrochloride 2.5g, be put into injection water 700ml, holding temperature is 65 DEG C Stirring and dissolving, hyperfiltration, it is 7.3 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, and encapsulating is gone out through 115 DEG C, pressure 0.2MPa Bacterium 30 minutes, every 5ml obtained injection;
The preparation of 7 duck plague disease injection of embodiment
It takes rimantadine hydrochloride 2.5g, dipyrimidinol 4g, be put into injection water 700ml, holding temperature is 65 DEG C Stirring and dissolving, hyperfiltration, it is 7.3 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, and encapsulating is gone out through 115 DEG C, pressure 0.2MPa Bacterium 30 minutes, every 5ml obtained injection;
The duck plague injection control efficiency of the present invention of test example 1 is investigated
800 duck plague sick ducks are randomly divided into 8 groups, test group 1-7 uses injection made from 1-7 of the embodiment of the present invention respectively It is treated, control group is treated using anti-0.5 milliliter of duck plague hyper-immune serum duck poison of the great high-tech of intramuscular injection state;Investigate result such as The following table 1:
The duck plague injection control efficiency of the present invention of table 1 is investigated
It is above-mentioned experiments have shown that, the present invention made of injection for prevent and treat duck plague disease, effect is preferable, and treatment cost is low, It is easily operated.

Claims (6)

1. a kind of control method of duck plague disease, which comprises the following steps:
(1) it the preparation of duck plague disease injection: takes acyclovir 1-4g, rimantadine hydrochloride 1-4g, dipyrimidinol 2-6g, be put into For injection in water 600-800ml, holding temperature is 60-70 DEG C of stirring and dissolving, and the sodium hydroxide of hyperfiltration, 0.5mol/L is molten It is 7.0-7.5 that liquid, which adjusts PH, and encapsulating sterilizes 30 minutes through 115 DEG C, pressure 0.2MPa, and every 5ml obtains injection;
(2) treatment of duck plague disease: illness duck is rejected into isolation treatment, gives injection injection 2-5ml of the present invention;
(3) duck plague disease is prevented: to sick duck is not suffering from, only being prevented using injection intramuscular injection 1-3ml/ of the invention.
2. the control method of duck plague disease according to claim 1, it is characterised in that: the system of step (1) duck plague disease injection It is standby: it takes acyclovir 2-3g, rimantadine hydrochloride 2-3g, dipyrimidinol 3-5g, be put into injection water 650-750ml, Holding temperature is 60-70 DEG C of stirring and dissolving, and hyperfiltration, it is 7.0-7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, is filled Envelope sterilizes 30 minutes through 115 DEG C, pressure 0.2MPa, and every 5ml obtains injection.
3. the control method of duck plague disease according to claim 1 or 2, it is characterised in that: (1) system of duck plague disease injection It is standby: it takes acyclovir 2.5g, rimantadine hydrochloride 2.5g, dipyrimidinol 4g, be put into injection water 700ml, heat preservation temperature Degree is 65 DEG C of stirring and dissolvings, hyperfiltration, and it is 7.0-7.5 that the sodium hydroxide solution of 0.5mol/L, which adjusts PH, encapsulating, through 115 DEG C, Pressure 0.2MPa sterilizes 30 minutes, and every 5ml obtains injection.
4. the control method of duck plague disease according to claim 1, it is characterised in that: injection PH tune described in step (1) Section is 7.3.
5. the control method of duck plague disease according to claim 1, it is characterised in that: the treatment of step (2) duck plague disease: will suffer from Sick duck rejects isolation treatment, gives injection injection 3.5ml of the present invention.
6. the control method of duck plague disease according to claim 1, it is characterised in that: step (3) duck plague disease prevention: to being not suffering from Sick duck, is only prevented using injection intramuscular injection 2ml/ of the invention.
CN201810836909.9A 2018-07-26 2018-07-26 A kind of control method of duck plague disease Withdrawn CN109157536A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810836909.9A CN109157536A (en) 2018-07-26 2018-07-26 A kind of control method of duck plague disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810836909.9A CN109157536A (en) 2018-07-26 2018-07-26 A kind of control method of duck plague disease

Publications (1)

Publication Number Publication Date
CN109157536A true CN109157536A (en) 2019-01-08

Family

ID=64898331

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810836909.9A Withdrawn CN109157536A (en) 2018-07-26 2018-07-26 A kind of control method of duck plague disease

Country Status (1)

Country Link
CN (1) CN109157536A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102580094A (en) * 2012-02-24 2012-07-18 赵双印 Medicine for treating fowl plague and duck plague
WO2012106509A1 (en) * 2011-02-02 2012-08-09 The Trustees Of Princeton University Sirtuin modulators as virus production modulators
CN107308324A (en) * 2017-06-29 2017-11-03 贞丰县食源特种养殖有限公司 A kind of traditional Chinese medicine injection for treating duck plague disease and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012106509A1 (en) * 2011-02-02 2012-08-09 The Trustees Of Princeton University Sirtuin modulators as virus production modulators
CN102580094A (en) * 2012-02-24 2012-07-18 赵双印 Medicine for treating fowl plague and duck plague
CN107308324A (en) * 2017-06-29 2017-11-03 贞丰县食源特种养殖有限公司 A kind of traditional Chinese medicine injection for treating duck plague disease and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
史万玉: "中兽药在家禽疾病防控中的应用", 《兽医导刊》 *

Similar Documents

Publication Publication Date Title
CN105198988B (en) Anti- Vibrio splindidus Yolk antibody and preparation method thereof
CN105153303B (en) A kind of Yolk antibody and preparation method thereof of prevention Duck parvovirus
CN105688202B (en) A kind of Vaccinum Encephalitis B composition and preparation method thereof
CN102168073A (en) Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
CN104258389B (en) A kind of vaccine combination and its preparation method and application
CN104162162B (en) A kind of anti-Schweineseuche compositions, lyophilized powder, preparation method and application
CN101259275A (en) Yolk antibody feed additive and injection for resisting sheep virosis and preparation thereof
CN102885914B (en) Traditional Chinese medicine oral liquid for treating chicken coccidiasis and preparation method thereof
CN106310247B (en) The preparation method of gosling plague inactivated vaccine and its inactivated vaccine of preparation
CN108295053B (en) Application of the schizandrin in enhancing PEDV vaccine immune response
CN109157536A (en) A kind of control method of duck plague disease
CN109045295A (en) A kind of application of vaccine adjuvant and preparation method thereof
CN105770881A (en) Mycoplasma gallisepticum (MG) and mycoplasma synoviae (MS) combined inactivate vaccine
CN108743932A (en) A kind of inactivated vaccine preparation method for preventing duck reovirus
CN111569059B (en) Antigen-antibody complex vaccine for poultry and preparation method thereof
CN105688204A (en) Meat duck parvovirus inactivated vaccine
CN103977414B (en) Freeze-dried antigen activity stabilizer and preparation method thereof
CN108273051B (en) The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine
CN105441394A (en) Avian influenza virus diluent and preparation method thereof
CN107158067A (en) It is a kind of to be used to prevent and treat Chinese medicine composition of swine eperythrozoonosis and its preparation method and application
CN102532311B (en) Yolk antibody for preventing and treating colibacillosis, preparation method for yolk antibody and feed additive
CN108158841A (en) Application of the quail egg active constituent ovoinhibitor glycoprotein in antiallergy
GB1580539A (en) Orally administrable vaccine
CN101250228A (en) Method for preparing bovine origin anti-avian influenza immune globulin
CN101265289A (en) Method for preparing porcine epidemic diarrhea resisting immune globulin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190108